Women in STEM: Bridging the gender gap
SurfsUp / Shutterstock.com
Effective support and guidance can achieve greater diversity in life sciences, say general counsel from Bristol Myers Squibb, AstraZeneca, The Chemours Company and Eli Lilly.
The gender gap and lack of diversity in the life sciences continues to be a sore point. Only 30% of the world’s scientific researchers are women, according to the United Nations Educational, Scientific and Cultural Organization.
The picture in IP is equally dismal. Overall, women make up just over a fifth of registered attorneys and agents and ethnic minorities comprise 6.5%, according to 2020 research carried out by the American Bar Association.
The association notes that there are more patent attorneys and agents named “Michael” in the US than there are racially diverse women in those roles. Currently, only 1.7% of all registered patent attorneys and agents are racially diverse women.
Life Sciences Intellectual Property Review (LSIPR) tracks the increasing challenges for intellectual property specialists in the rapidly evolving world of life sciences. From gene patents to stem cell research, we provide the very best news and analysis.
To continue reading this article and to access 4,500+ articles, our digital magazines and special reports published for LSIPR subscribers only then you will need a subscription.
If you are already subscribed please login.
Official LSIPR subscribers include:
Allen & Overy
Arnold & Siedsma
Birch, Stewart, Kolasch & Birch LLP (BSKB)
Carpmaels & Ransford
European Patent Office
George Washington Law School
Kirkland & Ellis International LLP
Marks & Clerk
NiKang Therapeutics Inc.
Powell Gilbert LLP
Procopio, Cory, Hargreaves & Savitch LLP
The United States Patent and Trademark Office (USPTO)
World Intellectual Property Office
Mentorship, D&I, Bristol Myers Squibb, AstraZeneca, The Chemours Company, Eli Lilly, UN, American Bar Association, minorities, racial equality, gender gap